"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
Descriptor ID |
D045744
|
MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
2002 | 0 | 2 | 2 |
2003 | 2 | 121 | 123 |
2004 | 1 | 305 | 306 |
2005 | 1 | 315 | 316 |
2006 | 6 | 296 | 302 |
2007 | 1 | 374 | 375 |
2008 | 3 | 354 | 357 |
2009 | 4 | 391 | 395 |
2010 | 2 | 415 | 417 |
2011 | 3 | 450 | 453 |
2012 | 2 | 407 | 409 |
2013 | 3 | 406 | 409 |
2014 | 1 | 428 | 429 |
2015 | 3 | 405 | 408 |
2016 | 0 | 426 | 426 |
2017 | 0 | 364 | 364 |
2018 | 1 | 335 | 336 |
2019 | 2 | 325 | 327 |
2020 | 0 | 278 | 278 |
2021 | 0 | 263 | 263 |
2022 | 0 | 122 | 122 |
2023 | 0 | 105 | 105 |
2024 | 0 | 22 | 22 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer. Nat Commun. 2024 Mar 19; 15(1):2461.
-
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells. Oncotarget. 2024 Mar 14; 15:220-231.
-
Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions. Sci Adv. 2024 Mar; 10(9):eadj3551.
-
p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer. BMC Cancer. 2024 Feb 19; 24(1):233.
-
CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. RNA. 2024 Feb 16; 30(3):281-297.
-
Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Sci Adv. 2024 Feb 16; 10(7):eadk1835.
-
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nat Commun. 2024 Feb 14; 15(1):1373.
-
Somatostatin Receptor Subtype-2 Targeting System for Specific Delivery of Temozolomide. J Med Chem. 2024 Feb 22; 67(4):2425-2437.
-
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation. Nat Commun. 2024 Feb 07; 15(1):1148.
-
Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy. Life Sci Alliance. 2024 Apr; 7(4).